Here we have presented a brief overview of the experimental and epidemiologic evidence suggesting that dysregulation of the progesterone-mediated RANK signaling pathway plays a critical role in the pathogenesis of BRCA1-associated breast cancer. The gene discussed is TNFRSF11A; the disease is breast cancer.